연구동향 분석

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Michael H. Le Yee Hui Yeo Biyao Zou Scott Barnet Linda Henry Ramsey Cheung Mindie H. Nguyen 2022년

논문상세정보
인용/피인용
' Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Metabolic syndrome
  • Smoking
  • Trends
  • Women
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,367 0

0.0%

' Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach' 의 참고문헌

  • Trends of cirrhosis-related mortality in the United States during the COVID-19pandemic : a cohort study
    Yeo YH [2022]
  • Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
    Han Ah Lee [2022]
  • The prevalence and incidence of NAFLD worldwide : a systematic review and meta-analysis
    Riazi K [2022]
  • The growing burden of disability related to nonalcoholic fatty liver disease : data from the Global Burden of Disease 2007-2017
    Paik JM [2020]
  • The growing burden of disability related to chronic liver disease in the United States : data from the Global Burden of Disease Study 2007-2017
    Paik JM [2021]
  • The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product : a meta-analysis
    Wu Y [2020]
  • The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
    Younossi ZM [2016]
  • Prevalence of nonalcoholic fatty liver disease in the female population
    Arshad T [2018]
  • Poor awareness of liver disease among adults with NAFLD in the United States
  • Pediatric non-alcoholic fatty liver disease
    Bush H [2017]
  • Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality
    Golabi P [2019]
  • Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Manne V [2018]
  • Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States
    Younossi ZM [2021]
  • Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
    Younossi Z [2019]
  • Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
  • Nonalcoholic fatty liver disease prevalence trends among adolescents and young adults in the United States, 2007-2016
    Arshad T [2021]
  • Nonalcoholic fatty liver disease in lean individuals in the United States
    Younossi ZM [2012]
  • Nonalcoholic fatty liver disease burden-Switzerland 2018-2030
    Goossens N [2019]
  • Nonalcoholic fatty liver disease burden-Saudi Arabia and United Arab Emirates, 2017-2030
    Alswat K [2018]
  • Nonalcoholic fatty liver disease burden : Australia, 2019-2030
    Adams LA [2020]
  • NASH leading cause of liver transplant in women : updated analysis of indications for liver transplant and ethnic and gender variances
    Noureddin M [2018]
  • Mortality of NAFLD according to the body composition and presence of metabolic abnormalities
    Golabi P [2020]
  • Modulation of insulin resistance in nonalcoholic fatty liver disease
    Khan RS [2019]
  • Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
    Estes C [2018]
  • Meta-analysis : global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021
    Li J [2022]
  • Liver transplantation (LT) for cryptogenic cirrhosis (CC)and nonalcoholic steatohepatitis (NASH) cirrhosis: data from the scientific registry of transplant recipients (SRTR): 1994 to 2016
    Golabi P [2018]
  • Improvements of fibrosis and disease activity are associated with improvement of patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis
    Younossi ZM [2021]
  • Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
    Xu Gao [2023]
  • Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease : a systematic review and meta-analysis
    Ye Q [2020]
  • Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence, incidence, and outcomes
    Younossi ZM [2016]
  • Global burden of nafld and nash : Trends, predictions, risk factors and prevention
    Younossi, Z [2018]
  • Fatty liver through the ages : nonalcoholic steatohepatitis
    Younossi ZM [2022]
  • Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016
    Le MH [2020]
  • Current smokers
  • Burden of nonalcoholic fatty liver disease in Canada, 2019-2030 : a modelling study
    Swain MG [2020]
  • Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa : data from global burden of disease 2009-2019
    Golabi P [2021]
  • Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population
    Wang J [2021]
  • Anti-fibrotic treatments for chronic liver diseases: The present and the future
  • American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings : co-sponsored by the American Association for the Study of Liver Diseases(AASLD)
    Cusi K [2022]
  • A global view of the interplay between nonalcoholic fatty liver disease and diabetes
    Stefan N [2022]
  • A global survey of physicians knowledge about nonalcoholic fatty liver disease
    Younossi ZM [2022]
  • A fundamental limitation of Markov models
    DelSole T [2000]
  • 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis